Product
LBL-033
1 clinical trial
1 indication
Indication
Advanced Malignant TumorsClinical trial
A Multicenter, Open Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of LBL-033 in the Treatment of Patients With Advanced Malignant Tumors.Status: Recruiting, Estimated PCD: 2026-03-31